Home
/
Jaguar Health, Inc.
/
Financials
/
Quarterly
Jaguar Health, Inc. — Quarterly Financials
Quarterly figures from SEC EDGAR XBRL filings (10-Q)
These figures are extracted from XBRL-tagged quarterly reports (10-Q) that Jaguar Health, Inc. filed with the SEC. Values are as reported for each individual quarter (Q1, Q2, Q3, Q4) — not cumulative year-to-date. Negative figures indicate a loss.
Revenue — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
$3.08M
Nov 14, 2025
Q2
2025
Jun 30, 2025
$2.98M
Aug 14, 2025
Q1
2025
Mar 31, 2025
$2.21M
May 15, 2025
Q3
2025
Sep 30, 2024
$3.11M
Nov 14, 2025
Q2
2025
Jun 30, 2024
$2.72M
Aug 14, 2025
Q1
2025
Mar 31, 2024
$2.35M
May 15, 2025
Q3
2024
Sep 30, 2023
$2.81M
Nov 13, 2024
Q3
2020
Sep 30, 2020
$2.77M
Nov 16, 2020
Q2
2020
Jun 30, 2020
$3.17M
Aug 13, 2020
Q1
2020
Mar 31, 2020
$869.0K
May 15, 2020
Q3
2020
Sep 30, 2019
$973.0K
Nov 16, 2020
Q2
2020
Jun 30, 2019
$1.71M
Aug 13, 2020
Q1
2020
Mar 31, 2019
$1.59M
May 15, 2020
Q3
2019
Sep 30, 2018
$1.13M
Nov 14, 2019
Q2
2019
Jun 30, 2018
$883.8K
Aug 14, 2019
Q1
2019
Mar 31, 2018
$804.4K
May 21, 2019
Q3
2018
Sep 30, 2017
$1.10M
Nov 19, 2018
Q2
2018
Jun 30, 2017
$896.5K
Aug 13, 2018
Q1
2018
Mar 31, 2017
$822.4K
May 15, 2018
Q3
2017
Sep 30, 2016
$50.4K
Nov 20, 2017
Revenue — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q2
2018
Jun 30, 2018
$883.8K
Aug 13, 2018
Q2
2018
Jun 30, 2017
$896.5K
Aug 13, 2018
Net Income — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
($9.50M)
Nov 14, 2025
Q2
2025
Jun 30, 2025
($10.41M)
Aug 14, 2025
Q1
2025
Mar 31, 2025
($10.46M)
May 15, 2025
Q3
2025
Sep 30, 2024
($9.85M)
Nov 14, 2025
Q2
2025
Jun 30, 2024
($9.49M)
Aug 14, 2025
Q1
2025
Mar 31, 2024
($9.23M)
May 15, 2025
Q3
2024
Sep 30, 2023
($7.78M)
Nov 13, 2024
Q2
2024
Jun 30, 2023
($12.15M)
Aug 13, 2024
Q1
2024
Mar 31, 2023
($12.20M)
May 14, 2024
Q3
2023
Sep 30, 2022
($12.52M)
Nov 14, 2023
Q2
2023
Jun 30, 2022
($9.37M)
Aug 14, 2023
Q1
2023
Mar 31, 2022
($17.99M)
May 15, 2023
Q3
2021
Sep 30, 2021
($12.19M)
Nov 17, 2021
Q2
2021
Jun 30, 2021
($14.08M)
Aug 13, 2021
Q1
2021
Mar 31, 2021
($12.01M)
May 17, 2021
Q3
2021
Sep 30, 2020
($7.87M)
Nov 17, 2021
Q2
2021
Jun 30, 2020
($9.24M)
Aug 13, 2021
Q1
2021
Mar 31, 2020
($7.94M)
May 17, 2021
Q3
2020
Sep 30, 2019
($7.56M)
Nov 16, 2020
Q2
2020
Jun 30, 2019
($16.72M)
Aug 13, 2020
Operating Income — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
($7.24M)
Nov 14, 2025
Q2
2025
Jun 30, 2025
($8.01M)
Aug 14, 2025
Q1
2025
Mar 31, 2025
($9.42M)
May 15, 2025
Q3
2025
Sep 30, 2024
($7.26M)
Nov 14, 2025
Q2
2025
Jun 30, 2024
($7.20M)
Aug 14, 2025
Q1
2025
Mar 31, 2024
($8.22M)
May 15, 2025
Q3
2024
Sep 30, 2023
($8.79M)
Nov 13, 2024
Q2
2024
Jun 30, 2023
($8.10M)
Aug 13, 2024
Q1
2024
Mar 31, 2023
($9.85M)
May 14, 2024
Q3
2023
Sep 30, 2022
($9.90M)
Nov 14, 2023
Q2
2023
Jun 30, 2022
($6.48M)
Aug 14, 2023
Q1
2023
Mar 31, 2022
($11.75M)
May 15, 2023
Q3
2022
Sep 30, 2021
($9.53M)
Nov 14, 2022
Q2
2022
Jun 30, 2021
($11.58M)
Aug 22, 2022
Q1
2022
Mar 31, 2021
($8.77M)
May 10, 2022
Q3
2021
Sep 30, 2020
($5.38M)
Nov 17, 2021
Q2
2021
Jun 30, 2020
($8.45M)
Aug 13, 2021
Q1
2021
Mar 31, 2020
($7.65M)
May 17, 2021
Q3
2020
Sep 30, 2019
($6.73M)
Nov 16, 2020
Q2
2020
Jun 30, 2019
($10.62M)
Aug 13, 2020